Biofrontera
BFRI
19 hedge funds and large institutions have $2.61M invested in Biofrontera in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
58% more funds holding
Funds holding: 12 → 19 (+7)
35% more capital invested
Capital invested by funds: $1.94M → $2.61M (+$675K)
1.03% more ownership
Funds ownership: 20.54% → 21.57% (+1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$156K |
| 2 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$110K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$104K |
| 4 |
Jane Street
New York
|
+$92K |
| 5 |
HF
HRT Financial
New York
|
+$42.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$173K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$32.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31.2K |
| 4 |
Citigroup
New York
|
-$9.58K |
BFRI Hedge Fund Activity: Q2 2026 in Review
19 of the 8,334 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2026, worth a combined $2.61M — up 35% from $1.94M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BFRI positions and 2 closed out — a net gain of 7 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $156K. The largest seller was AIGH Capital Management, cutting an estimated $173K.
- 19 institutional investors held Biofrontera (BFRI) as of Q2 2026, up from 12 in Q1 2026.
- Funds reported $2.61M of Biofrontera stock for Q2 2026, up 35% quarter-over-quarter.
- 9 funds opened new Biofrontera positions in Q2 2026 and 2 closed out, a net change of +7 holders.
- The largest Biofrontera buyer in Q2 2026 was Renaissance Technologies, an estimated $156K added.
- The largest Biofrontera seller in Q2 2026 was AIGH Capital Management, an estimated $173K sold.
Based on aggregated 13F filings for Q2 2026.